Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 98-102, 2020.
Article
in English
| WPRIM
| ID: wpr-811441
ABSTRACT
Hepatic hydrothorax is a transudative pleural effusion that complicates advanced liver cirrhosis. Patients refractory to medical treatment plus salt restriction and diuretics are considered to have refractory hepatic hydrothorax and may require transjugular intrahepatic portosystemic shunt (TIPS) or liver transplant. Successful antiviral therapy reduces the incidence of some complications of cirrhosis secondary to HCV infection. We report a case of hepatic hydrothorax in a 55-year-old female patient with HCV cirrhosis, which exhibited a spontaneous decrease in pleural effusion after direct antiviral agent (DAA) therapy. In cases of HCV cirrhosis, DAAs are worth administering before treatment by TIPS or liver transplantation.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Pleural Effusion
/
Fibrosis
/
Portasystemic Shunt, Surgical
/
Incidence
/
Liver Transplantation
/
Hepacivirus
/
Hepatitis C, Chronic
/
Diuretics
/
Hepatitis, Chronic
Type of study:
Incidence study
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
The Korean Journal of Gastroenterology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS